** Shares in Zivo Bioscience Inc ZIVO.O up 172.9% at $7.64
after hitting highest level since May 27. Zivo was one of the
most actively traded stocks on U.S. exchanges on Monday
** The company, which is developing bioactive compounds from
algal culture, targeting human and animal diseases such as
poultry coccidiosis, bovine mastitis, human cholesterol, and
rheumatoid arthritis, rose as high as $7.90
** It had traded ~55 mln shares in less than an hour into
the regular session, already a record level for a single session
and well above its 9.28 mln shares outstanding, according to
Refinitiv
** Monday's turnover so far was ~$402 mln, Market cap was
~$64 mln, compared to just under $26 mln at end of last session
** ZIVO shares still down ~9% YTD
** A company representative gave no immediate comment
(Reporting By Sinéad Carew)
((sinead.carew@thomsonreuters.com; +1 (646) 223 6186; Reuters
Messaging: sinead.carew.thomsonreuters.com@reuters.net))